After dry spell, Boston has a new unicorn

After a nearly three-month dry spell in companies crossing the $1 billion valuation mark., Wasabi Technologies Inc. has become the region’s latest unicorn after raising $125 million in Series D round led by L2 Point Management. Read More

Read More

Whistleblower due $266.4M in Biogen drug kickback settlement

The whistleblower’s $266 million share of Biogen’s $900 million settlement to resolve allegations that the company paid kickbacks to physicians to induce them to prescribe the company’s multiple sclerosis drugs is the largest whistleblower award in US history. Read More

Read More